Price Update,effective enamel remineralization with P11-4

The field of dental medicine is continuously evolving, seeking innovative solutions to combat common oral health issues. Among the most promising advancements is the emergence of peptide 11 4, a remarkable self-assembling peptide with the potential to revolutionize how we approach enamel regeneration and the treatment of early dental caries. This synthetic, pH controlled self-assembling peptide is not merely a theoretical concept; it is a tangible therapeutic agent backed by growing scientific evidence and a clear search intent focused on its application in oral care.

At its core, peptide 11 4 functions as a biomimetic agent. Biomimetic refers to the imitation of nature's models, processes, and systems. In the context of dental health, this means leveraging biological principles to encourage the natural repair mechanisms of the teeth. Peptide 11 4 achieves this by facilitating biomimetic mineralization, a process that encourages the formation of new mineral crystals within damaged tooth structures. This is particularly significant for addressing early carious lesions, often referred to as white spot lesions.

The scientific community has extensively researched the capabilities of peptide 11 4. Studies highlight its ability to permeate into early lesions, acting as a scaffold for new hydroxyapatite crystals to form. Hydroxyapatite is the primary mineral component of tooth enamel, and its regeneration is crucial for restoring the structural integrity and protective function of the enamel. The peptide's unique structure allows it to self-assemble into 3-dimensional fibrillar scaffolds, creating a framework that guides the deposition of these essential mineral crystals. This intricate process effectively reverses the demineralizing process, a key step in the progression of dental decay.

One of the most exciting aspects of peptide 11 4 is its synergistic potential when combined with other dental treatments. Research indicates that P 11 -4 in combination with fluoride application demonstrates superior efficacy in treating early carious lesions compared to fluoride alone. This combination therapy leverages the remineralizing power of fluoride with the biomimetic scaffolding provided by peptide 11 4, leading to enhanced enamel repair. Furthermore, studies have explored its combination with Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACPF), another remineralizing agent, suggesting a multifaceted approach to oral health restoration. While some studies have shown CPP-ACPF to possess a superior antibacterial effect, the combination of P11-4 with fluoride varnish or NaF has exhibited comparable antibacterial effects.

The mechanism of action for peptide 11 4 is rooted in its amphiphilic and pH-triggered nature. This means it has both water-loving and water-repelling properties, and its self-assembly behavior is influenced by changes in the surrounding pH. This characteristic allows it to respond to the specific environment within early carious lesions, where pH levels can fluctuate. When the conditions are optimal, typically at pH > 8 and low ionic strength, self-assembling peptides mask the initial caries lesions by initiating the remineralization process. This pH sensitivity is a critical factor in its targeted action.

The therapeutic applications of peptide 11 4 extend beyond just caries management. It can be used in biomimetic mineralization, enamel regeneration and oral care agent. Its ability to interact with collagen, a key protein in dentin, also suggests its potential in dentin remineralization. This opens doors for treating a broader spectrum of dental issues beyond superficial enamel damage. The molecular weight of Oligopeptide P11-4 is approximately 1595.67, with a chemical formula of C72H98N20O.

The scientific literature underscores the efficacy of peptide 11 4 in promoting effective enamel remineralization with P11-4. Systematic reviews and meta-analyses have concluded that self-assembling peptide P11-4 is a noninvasive, tooth-preserving biomimetic treatment for active initial caries lesions. This non-invasive nature is a significant advantage, offering a less aggressive alternative to traditional restorative procedures like fillings, especially for early-stage decay. The SAP P11-4 forms a hydrogel with a three-dimensional network structure that aids in this repair process.

The ongoing research into peptide 11 4 is extensive, with numerous studies exploring its clinical performance and various applications. Investigations into its effects on orthodontic treatment highlight its potential to improve the remineralization of subsurface lesions that can occur during orthodontic therapy. Furthermore, emerging research suggests that self-assembling peptide P11-4 can modulate cellular metabolism and regulate the expression of genes, hinting at even broader biological interactions and therapeutic possibilities.

In summary, peptide 11 4 represents a significant leap forward in dental innovation. Its capacity for biomimetic mineralization, its ability to self-assemble into 3-dimensional fibrillar scaffolds, and its synergistic potential with agents like fluoride make it a powerful tool for enamel regeneration and the treatment of early enamel carious lesions. As research continues,